Cargando…
Insulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes
Sarcopenia is defined as an age-related loss of skeletal muscle mass and strength, and is a major cause of disability and mobility limitations. Recent studies have demonstrated that type 2 diabetes and insulin signaling deficiencies contribute to the progression of sarcopenia, suggesting that a suff...
Autores principales: | Bouchi, Ryotaro, Fukuda, Tatsuya, Takeuchi, Takato, Nakano, Yujiro, Murakami, Masanori, Minami, Isao, Izumiyama, Hajime, Hashimoto, Koshi, Yoshimoto, Takanobu, Ogawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486921/ https://www.ncbi.nlm.nih.gov/pubmed/28246927 http://dx.doi.org/10.1007/s00223-017-0251-x |
Ejemplares similares
-
Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2017) -
Ratio of visceral‐to‐subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes
por: Fukuda, Tatsuya, et al.
Publicado: (2017) -
Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study
por: Fukuda, Tatsuya, et al.
Publicado: (2017) -
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study
por: Bouchi, Ryotaro, et al.
Publicado: (2017) -
Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
por: Fukuda, Tatsuya, et al.
Publicado: (2017)